While respondents widely agree on many important benefits of ePrescribing, there is less of a consensus when it comes to cost savings. Two out of three of those polled report being more likely to prescribe a generic or plan- preferred drug when using an ePrescribing system. However, one in four physicians believe that the technology may not reduce costs for their patients or their practice.
"We know that ePrescribers are more likely to engage in cost-savings practices, such as prescribing a lower-cost alternative, and in some cases it may mean a substantial reduction in a patient's costs," said John Driscoll, president of new markets for Medco. "What is striking about these survey findings is that physicians who make the transition to ePrescribing become big fans of what the technology does for their practice and their patients, and it's important that we continue to work toward changing the perception among doctors who are not making that connection."
Results released in 2007 from the SEMI program support the survey
findings that ePrescribing improves safety and formulary compliance. A
review of 3.3 million electronic prescriptions written by physicians
participating in SEMI showed the following:
-- When a formulary alert was presented, the physician changed the
prescription 39 percent of the time to comply with formulary
-- There were more than 1 million alerts sent on moderate to severe drug-
to-drug risks, resulting in nearly 423,000 (41 percent) of those
prescriptions being changed or canceled by the prescribing doctor.
-- More than 100,000 medication allergy alerts were presented, of which
more than 41,000 (41 percent) were acted upon.
|SOURCE Southeastern Michigan ePrescribing Initiative|
Copyright©2008 PR Newswire.
All rights reserved